Skip to main content

Table 3 The risk of receiving ICD, CRT-P and CRT-D in patients with type 2 diabetes mellitus compared to controls

From: Implantable cardioverter defibrillator and cardiac resynchronization treatment in people with type 2 diabetes: a comparison with age- and sex matched controls from the general population

 

Hazard ratio [95% CI]

P-value

ICD

 Unadjusted

2.14 [1.96–2.33]

 < 0.0001

 Model 1a

2.14 [1.96–3.33]

 < 0.0001

 Model 2b

1.51 [1.38–1.65]

 < 0.0001

 Model 3c

1.32 [1.21–1.45]

 < 0.0001

CRT-P

 Unadjusted

2.63 [2.36–2.94]

 < 0.0001

 Model 1a

2.71 [2.43–3.03]

 < 0.0001

 Model 2b

2.09 [1.86–2.34]

 < 0.0001

 Model 3c

1.74 [1.55–1.95]

 < 0.0001

CRT-D

 Unadjusted

2.87 [2.46–3.36]

 < 0.0001

 Model 1a

2.88 [2.46–3.37]

 < 0.0001

 Model 2b

2.00 [1.70–2.35]

 < 0.0001

 Model 3c

1.69 [1.43–1.99]

 < 0.0001

  1. CI confidence interval, ICD Implantable cardioverter defibrillator, CRT-P cardiac resynchronization therapy-pacemaker, CRT-D cardiac resynchronization therapy-defibrillator
  2. aModel 1: Adjusted for sex, age, marital status, income, education, country of birth
  3. bModel 2: Adjusted for model 1 and in addition previous CAD
  4. cModel 3: Adjusted for the model 2 and in addition previous CHF
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840